153 related articles for article (PubMed ID: 36524081)
1. A clinical risk model for assessing the survival of patients with stage IA-IIA non-small cell lung cancer after surgery.
Qian JY; Li ZX; Wu LL; Song SH; Li CW; Lin WK; Xu SQ; Li K; Xie D
J Thorac Dis; 2022 Nov; 14(11):4285-4296. PubMed ID: 36524081
[TBL] [Abstract][Full Text] [Related]
2. Nomogram to Predict Cancer Specific Survival in Patients with Pathological Stage IA Non-small Cell Lung Cancer.
Cai JS; Dou XM; Li JB; Yang MZ; Xie CL; Hou X; Yang HX
Semin Thorac Cardiovasc Surg; 2022; 34(3):1040-1048. PubMed ID: 34216749
[TBL] [Abstract][Full Text] [Related]
3. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
4. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
5. A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.
Shang X; Yu H; Lin J; Li Z; Zhao C; Sun J; Wang H
J Oncol; 2020; 2020():7863984. PubMed ID: 32565807
[TBL] [Abstract][Full Text] [Related]
6. Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy.
Wo Y; Yang H; Zhang Y; Wo J
Front Oncol; 2019; 9():1385. PubMed ID: 31921643
[No Abstract] [Full Text] [Related]
7. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
[TBL] [Abstract][Full Text] [Related]
8. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
Huang X; Hu P; Yan F; Zhang J
Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
[No Abstract] [Full Text] [Related]
9. A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer.
Yang H; Li X; Shi J; Fu H; Yang H; Liang Z; Xiong H; Wang H
Cancer Manag Res; 2018; 10():6611-6626. PubMed ID: 30584357
[TBL] [Abstract][Full Text] [Related]
10. A Population-Based Study on the Prognostic factors and Efficacy of Adjuvant Chemotherapy in the Postoperative Stage for Patients with Stage IIA Non-Small Cell Lung Cancer.
Wang W; Teng F; Bu S; Xu W; Cai QC; Jiang YQ; Wang ZQ
Risk Manag Healthc Policy; 2022; 15():1581-1592. PubMed ID: 36046766
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of nomograms for predicting overall and cancer-specific survival in young patients with non-small cell lung cancer.
Peng Y; Sun Y
J Thorac Dis; 2020 Apr; 12(4):1404-1416. PubMed ID: 32395278
[TBL] [Abstract][Full Text] [Related]
12. The Positive Lymph Node Ratio Predicts Survival in T
Liao Y; Yin G; Fan X
Front Oncol; 2020; 10():1356. PubMed ID: 32903785
[No Abstract] [Full Text] [Related]
13. Nomogram for Predicting the Relationship between the Extent of Visceral Pleural Invasion and Survival in Non-Small-Cell Lung Cancer.
Wang F; Li P; Li F
Can Respir J; 2021; 2021():8816860. PubMed ID: 34122679
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
15. Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer.
Deng J; Ren Z; Wen J; Wang B; Hou X; Xue Z; Chu X
Cancer Manag Res; 2018; 10():6143-6156. PubMed ID: 30538562
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study.
Liao Y; Wang X; Zhong P; Yin G; Fan X; Huang C
Oncol Lett; 2019 Dec; 18(6):5905-5916. PubMed ID: 31788064
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
18. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
19. A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy.
Zeng Y; Mayne N; Yang CJ; Liu J; Cui F; Li J; Liang W; He J;
Transl Lung Cancer Res; 2021 Apr; 10(4):1690-1699. PubMed ID: 34012785
[TBL] [Abstract][Full Text] [Related]
20. Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer.
Tu Z; Tian T; Chen Q; Li C
J Oncol; 2021; 2021():8052752. PubMed ID: 34335761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
